HAK-actin, a U-ExM-compatible probe to image the actin cytoskeleton Authors: Olivier Mercey, Luc Reymond, Florent Lemaître, Isabelle Mean, Marine H Laporte, Marine Olivetta, Karin Sadoul, Omaya Dudin, Virginie Hamel, Paul Guichard Published: 2026 ABSTRACT SummaryExpansion microscopy (ExM) enables super-resolution imaging by physically enlarging biological samples. While ExM has been successfully applied to study the intracellular microtubule cytoskeleton, reliable probes for visualizing actin fibers remain limited. Here, we present HAK-actin, an engineered actin probe compatible with ultrastructure expansion microscopy (U-ExM). We show that HAK-actin delivers robust and uniform actin staining across diverse systems, including human cells, microbial eukaryotes, and mouse retinal tissue. This tool provides a simple, versatile, and reproducible solution for actin cytoskeleton visualization, addressing a critical need in cell biology.Keywords: actin, cytoskeleton, expansion microscopy, super resolution, cryo-ExM, iU-ExM Introduction Expansion microscopy revolutionized the super-resolution field, giving access to the nanoscale molecular organization of the cell by magnifying the biological specimen itself.1,2,3,4 The microtubule network has been largely characterized by expansion microscopy3,4,5,6,7; however, very few applications have targeted actin filaments, yet widely studied across biology fields. To date, actin visualization using expansion microscopy has been achieved using antibodies directed against either endogenous actin3,8 or genetically encoded actin probes, such as IntAct9 or Lifeact.3 However, their applicability is limited: antibody-based methods depend on the availability of species-specific reagents, while genetically encoded probes require efficient transfection or genetic manipulation. More recently, an alternative strategy has been developed to specifically visualize F-actin using phalloidin (PHALLO) conjugated to trifunctional linkers (such as TRITON), which can be grafted onto hydrogels for ExM.10,11,12 This method offers the advantage of leveraging PHALLO’s high affinity for F-actin, enabling visualization across multiple species. However, they rely on a pre-expansion labeling strategy that constrains fluorophore selection,13 leads to volumetric signal dilution after expansion,14 and ultimately limits the achievable resolution.5,15 Furthermore, this labeling strategy is sometimes incompatible with some protist species protected by protective structures such as cell walls, which often hinder labeling and antibody permeability.16,17 These limitations highlight the need for more versatile and universally compatible linker chemistries to enhance the applicability and performance of ExM-based imaging approaches. Results Here, we aimed to develop actin probes that are compatible with post-expansion labeling amplification, thereby overcoming fluorochrome limitations and minimizing signal dilution. To achieve this, we designed a probe suited for the ultrastructure expansion microscopy (U-ExM) protocol,18 which is adapted from the magnified analysis of the proteome (MAP) method.19 MAP preserves the entire proteome, enabling post-expansion labeling. U-ExM is particularly adapted for studying the actin cytoskeleton, as it maintains the molecular architecture of subcellular structures. U-ExM is also compatible with cryo-fixation (Cryo-ExM), an extension of the method that avoids artifacts due to chemical fixation, thereby optimizing cellular architecture preservation.3 Moreover, U-ExM does not require specific anchoring molecules, as the acrylamide within the swellable polymer is directly cross-linked to primary amines of the entire proteome using simple formaldehyde treatment. Based on this property, we hypothesized that incorporating lysine residues, containing primary amines, into the well-characterized F-actin probes jasplakinolide (JASP) or PHALLO would facilitate their retention within the hydrogel, as previously proposed.1,20 First, to evaluate probe anchoring within the hydrogel, we first synthetized two JASP-based probes, both carrying an Alexa 488 fluorochrome known to withstand expansion process21; one probe incorporated four lysine residues (JASP-K4-488), while the other did not (JASP-488) (Figure 1A). Both probes were assessed in the osteosarcoma cell line U2OS, where actin cytoskeleton staining is easily assessed. After paraformaldehyde (PFA) fixation and cell permeabilization, actin probes were added for an hour, followed by either direct fluorescence imaging or processing for U-ExM (Figure 1B). After successful validation of these probes prior to expansion (Figure S1A), we analyzed their retention after expansion. While JASP-488 produced no signal compared to the anti β-actin antibody control, the addition of lysine residues enabled JASP-K4-488 to effectively anchor to the hydrogel, as demonstrated by an increase in fluorescence intensity (Figures 1C, 1D, and 1G). Despite this improvement, the signal appeared weak compared to background, likely due to the volumetric dilution of the fluorochrome within the expanded hydrogel. HAK probe efficiencies in expanded U2OS cells (A) Chemical structures of three actin probes designed for U-ExM and mainly used in this study. All of them are composed of the jasplakinolide (JASP) molecule coupled to a PEG-moiety and a propargylglycine. On JASP-488, an Alexa 488 fluorophore is directly coupled to JASP. Both JASP-K4-488 or JASP-K4-HA (HAK-actin) have been designed with four lysine residues and an Alexa 488 or an HA-tag, respectively. (B) Workflow of HAK-actin probe use in U-ExM. The probe is added for 1 h after cell fixation (PFA 4% and permeabilization with PBS Tween 0.2%), and cells are then processed for expansion. (C–F) Representative widefield images of PFA-fixed and expanded U2OS cells treated with different actin probes. Actin probe staining (probe directly coupled to the Alexa 488 fluorophores or revealed through immunostaining post-expansion using anti-HA antibodies) is shown in green, anti-β-actin staining in magenta, and nuclei in cyan (DAPI). Scale bars: 10 μm. The right panel shows the HAK-probe signals normalized among all conditions, and an inset is depicted just on the right. Scale bars: 2 μm. (G) Quantification of the fluorescence intensity normalized against background of actin probes in the different conditions analyzed in (C–F) (n = 15 cells with 3 independent experiments per conditions). ns, non-significant; ∗∗∗∗p < 0.0001 by Kruskal-Wallis test. (H) Inset of the JASP-K4-HA (HAK-actin) to highlight the overlap between the actin probe signal and β actin staining. Scale bars: 2 μm. (I) Fluorescence intensity plot profile revealing the colocalization of HAK-actin and actin antibody measured in 15 different regions of interest. To address this major limitation, frequently reported in various expansion microscopy experiments,13 we added a post-fixation step using PFA and glutaraldehyde (GA). However, while this approach improved the signal intensity, the overall enhancement remained modest (Figures S1B and S1C). To achieve stronger labeling, we designed and synthesized an actin probe that is added before expansion but enables post-expansion immunolabeling and amplifies signal intensity through the incorporation of a hemagglutinin (HA) tag (JASP-K4-HA) (Figure 1A). The HA tag is widely used in cell biology as an epitope tag for protein detection and purification via immune recognition with commercial antibodies. It consists of a short peptide sequence (YPYDVPDYA) derived from the HA protein of the influenza virus. As expected for this post-labeling strategy, JASP-K4-HA enabled clear visualization of actin fibers and produced strong signal amplification (Figure 1E). Moreover, this probe offers flexibility in fluorophore selection, as it can be combined with conventional secondary antibodies that can be conjugated to a wide range of fluorochromes. We refer to this design as HAK, reflecting the incorporation of both an HA tag and lysine (K) residues. To evaluate the signal enhancement achieved through post-expansion immunostaining, we measured the fluorescence intensities of the different probes in expanded U2OS cells. Our measurements revealed a 4-fold increase in signal intensity for JASP-K4-HA compared to JASP-K4-488, demonstrating the enhanced signal provided by the HA tag in the HAK probe design (Figures 1E and 1G). To test the versatility of this approach, we next designed a PHALLO-based probe, following the same strategy (PHALLO-K4-HA) (Figures 1F, 1G, and S2). While we noticed that PHALLO-K4-HA displayed a slightly lower signal (∼1.5-fold decrease) albeit non-significant compared to JASP-K4-HA, we measured a 2-fold increase in signal intensity compared to a JASP-K4-488 probe (Figures 1F and 1G). Importantly, the specificity of both HAK-probes was confirmed by their colocalization with the immuno-labeled β-actin (Figures 1H, 1I, S1D, and S1E). Encouraged by the efficiency of the HAK probe design, we next explored whether alternative types of retention molecules could further enhance probe anchoring. We tested different amino acids bearing a side chain amino group: Lysine (K4, original design), diaminopropionic acid (DAP), ornitine (ORN), and 4-aminophenylalanine (4AF) (Figures 2A and S2). Signal intensity measurements, used as an indicator of anchoring efficiency, revealed that K4 and 4AF residues provided the highest retention within the hydrogel (Figures 2A and 2B). Therefore, the best HAK-probe design chosen for this study, JASP-K4-HA, was dubbed HAK-actin. It includes the JASPs actin ligand, four lysine residues, and an HA tag (Figure 1A). Optimization of HAK probes with different linkers and fixation conditions (A) Representative widefield images of expanded U2OS cells treated with several actin probes bearing different anchoring linkers: lysines (K4), diaminopropionic acid (DAP), ornithine (ORN), and 4-aminophenylalanine (4AF). Actin probes (normalized across images) are shown in green, β-actin antibodies in magenta, and DAPI in cyan. Scale bars: 10 μm. Image intensities are calibrated to the JSAP-K4-HA signal, which results in an almost undetectable signal for JASP-ORN-HA. (B) Quantification of the fluorescence intensities normalized to background for the different probes (n = 15 cells; N = 3 independent experiments per conditions). ns, non-significant; ∗∗∗∗p < 0.0001 by Kruskal-Wallis test. (C) Workflow of HAK-actin use in cryo-ExM. The probe is added either during the freeze substitution process in acetone (strategy 1) or in PBS-Tween 0.2% just before the expansion microscopy process (strategy 2). (D) Representative widefield images of cryo-fixed and expanded U2OS cells treated with either JASP-K4-488 or HAK-actin during the freeze substitution step (strategy 1) or just before the expansion process (strategy 2). Actin probes are shown in green (normalized across images on the right), β-actin antibodies in magenta, and DAPI in cyan. (E) Quantification of the signal intensities (normalized on background) in the different cryo-conditions (n = 15 cells; N = 3 independent experiments per conditions). Ns, non-significant; ∗∗p < 0.01 and ∗∗∗p < 0.001 by Kruskal-Wallis test. (F) Quantification of the signal intensities (normalized on background) observed with cryo-fixation conditions or with PFA fixation (n = 15 cells; N = 3 independent experiments per conditions). ∗p < 0.05 and ∗∗∗∗p < 0.0001 by Mann-Whitney test. Note that some values are the same as in Figures 1G and 2E for direct comparison. Since chemical fixation can introduce artifacts in cell architecture,22,23 we next tested the compatibility of these actin probes with Cryo-ExM, which better preserves cellular ultrastructure through cryo-fixation and freeze substitution3 (Figures 2C–2F). We incorporated actin probe JASP-K4-488 or HAK-actin into either the acetone during the freeze substitution process (strategy 1) or in PBS-Tween 0.2% just before the expansion microscopy process (strategy 2) (Figure 2C). Both strategies successfully yielded detectable actin signals (Figures 2D and 2E). Notably, incorporation during freeze substitution produced a substantially higher signal, likely due to the longer incubation time in strategy 1. We also consistently observed stronger labeling with HAK-actin compared to JASP-K4-488 (Figure 2E), further underscoring the robustness of the post-labeling HAK-probe strategy across fixation conditions. We thus concluded that the HAK probes are compatible with cryo-ExM, although the signal was slightly lower than under PFA fixation (Figure 2F). This compatibility represents a significant advantage for imaging cellular architecture, as Cryo-ExM can also be used to visualize membranes. To assess this, we used HAK-actin on cryofixed U2OS cells and successfully obtained images where membranes (stained with mCLING24,25) and actin cytoskeleton were clearly labeled (Figure S3). Notably, actin bundles were aligned with membrane staining detected in the mCLING channel, potentially indicating membrane deformation or groove formation along actin fiber cables (Figure S3A, white arrows). This approach further enabled the simultaneous visualization of membranes, microtubules, and the actin cytoskeleton in their native organization (Figure S3B). Next, we applied HAK-Actin on regular chemically fixed cells to image the cleavage furrow, a transient, actin-rich structure that participates in daughter cell separation during cytokinesis (Figure 3A). Using a single z image (Figure 3A, left panel), we clearly observed the enrichment of the actin staining at the interface between the two daughter cells (white arrow), whereas the full projection of the cells highlights the presence of filopodia surrounding the two daughter cells (Figure 3A, right panel, red arrows). We also evaluated the compatibility of HAK-actin with the iterative iU-ExM protocol, which achieves up to 16-fold expansion of biological specimens.4 HAK-actin successfully labeled actin filaments in U2OS cells expanded using iU-ExM, demonstrating its suitability for high-resolution visualization under these conditions (Figure 3B). HAK-actin in several mammalian cells and tissue models (A) Widefield image of PFA-fixed expanded U2OS cells labeled with HAK-actin and DAPI, highlighting the actin enrichment at the level of the cleavage furrow. Left panel is a single z image plane highlighting the intense actin staining (green) at the cleavage furrow (white arrow), whereas right panel is a full z projection of the cells where HAK-actin is color-coded with “spectrum” and DAPI is color-coded with “fire” for z positions (filopodia highlighted with red arrows). Scale bars: 10 μm. (B) A widefield image of cryo-fixed U2OS cells processed for iU-ExM and stained for HAK-actin (green) and β-actin (magenta). Scale bars: 2 μm. (C) Confocal images of expanded immature (4DIV) glutamatergic neurons stained with the HAK-actin (green) and tubulin (magenta) revealing the actin network in growth cones of immature neurons. Scale bars: 5 μm. (D) Confocal images of expanded mature (21DIV) glutamatergic neurons stained with the HAK-actin (green) and tubulin (magenta) showing dendritic spine diversity in mature neurons (21 DIV). Scale bars: 2.5 μm. (E) Widefield images of expanded human activated platelets stained with tubulin in magenta and HAK-actin (left) or PHALLO-K4-HA (right) in green. Stress fibers are highlighted with orange arrowheads and actin nodules with white arrowheads. Scale bars: 5 μm. (F) Widefield images of expanded murine photoreceptor cell cilia stained with tubulin in magenta and β-actin (left) or HAK-actin (right) in green. Scale bars: 500 nm. To further assess the versatility of HAK-actin, we tested its performance in various mammalian cells and tissue models. We first investigated human glutamatergic neurons at different stages of differentiation, where actin network plays a critical role in organizing distinct subcellular compartments (Figures 3C and 3D). In immature neurons (4 DIV; Figure 3C), the actin network is particularly important for the structural organization of growth cones, which facilitate connections with their target neurons during development.26 Application of HAK-actin on expanded neurons enabled visualization of the canonical ultrastructure of growth cones, revealing peripheral actin fibers, lamellipodia, and filopodia surrounding the microtubule network, as well as their interactions with neighboring cells (Figure 3C). At mature stage (21DIV; Figure 3D), glutamatergic neurons start to establish dendritic spines, specific structures crucial for synaptic transmission. The actin cytoskeleton provides structural integrity to these spines, dictating their characteristic morphologies. Here again, HAK-actin labeling on expanded neurons allowed for the identification of dendritic spines exhibiting different morphological subtypes, including thin, mushroom, and cup-shaped spines, as previously reported in the literature.27 We next imaged activated human platelets, which undergo massive actin reorganization from actin nodules, i.e., a podosome-like organization,28 to actin stress fibers crossing the platelet longitudinally.29 While in non-expanded platelets a precise actin organization was not visible (Figure S4A), the use of HAK-probes, HAK-actin or PHALLO-K4-HA, on expanded platelets clearly revealed two typical examples of actin organizations, stress fibers and actin nodules (Figure 3E, orange and white arrowheads, respectively).29 To extend these findings to more complex tissues, we next examined actin labeling in mouse retina that we previously studied using U-ExM.30,31,32 Recent studies suggest that actin accumulates above the connecting cilium of photoreceptor cells and participates in the membrane disc formation of the outer segment cilium, crucial for visual acuity.33 We compared the actin signal obtained using an anti β-actin antibody to the signal obtained with HAK-actin, followed by post-expansion immunolabeling with anti-HA antibodies (Figure 3F). Both strategies exhibited an actin signal at the level of the bulge region,32 where microtubules enlarge and where membrane discs are formed. Notably, HAK-actin yielded a clearer signal with reduced background, validating its utility for actin imaging in expanded tissue samples and demonstrating that HAK-actin can diffuse throughout thick samples such as the retina. Finally, to determine whether HAK-actin can be used as a broad-spectrum U-ExM actin markers, we tested its efficiency in microbial eukaryotes. Microbial eukaryotes display diverse cytoskeletal features due to their flexible life cycles and are often impermeable to antibody labeling due to protective layers like cell walls. However, recent work showed that U-ExM enhances antibody accessibility for immunostaining and improves resolution as previously shown for microtubules.17,34,35,36 Genetic tagging provides an alternative approach, but many species remain genetically intractable, and antibodies recognizing actin are often unavailable or species-specific. We first focused on the ichthyosporean Sphaeroforma arctica, one of the closest living relatives of animals, in which PHALLO-based staining has revealed a filamentous actin network decorating furrow ingressions during cellularization, like early Drosophila embryogenesis.37,38,39 We compared unexpanded and U-ExM-expanded S. arctica cells labeled with JASP-488, JASP-K4-488, or HAK-actin, followed by conventional immunofluorescence or U-ExM (Figure 4A). We found that JASP-488 stains unexpanded cells but fails to label actin in expanded samples, as expected, since this probe is not retained within the hydrogel (Figures 4A and 4B). JASP-K4-488, while most likely retained in the hydrogel, was insufficient to improve staining efficiency in expanded cells, likely due to a loss of fluorophore intensity under U-ExM conditions. By contrast, HAK-actin, detected with anti-HA antibodies, was not visible in unexpanded cells but efficiently labeled expanded S. arctica cells, clearly highlighting actin at furrow ingressions during cellularization (Figures 4A–4C). Thus, HAK-actin, via post-expansion immunolabeling, enables visualization of actin structures in this species that conventional anti-actin antibodies could not reveal, even after expansion (Figures 4B and 4C). Unveiling actin network in microbial eukaryotes (A) Sphaeroforma arctica cells labeled for actin (green) using JASP-488, JASP-K4-488, and HAK-actin and for tubulin (magenta) imaged as non-expanded samples, or after U-ExM, using widefield microscopy. Note that U-ExM enables both antibody and probe-based staining in this cell-walled species, revealing its actin and microtubule networks. Scale bars: 10 μm. (B) Boxplot showing the efficiency of antibody and probe-based staining for actin and tubulin in S. arctica under non-expanded (immunofluorescence, IF) versus expanded (U-ExM) conditions. While U-ExM facilitates tubulin immunostaining, actin antibodies do not stain effectively, whereas HAK-actin in combination with an anti-HA antibody successfully label filamentous actin (n > 30 cells per replicate, 3 independent replicates were performed). ns: non-significant, ∗∗∗∗p < 0.0001 by t test. (C) U-ExM samples of S. arctica undergoing actomyosin-dependent cellularization, stained with the HAK-actin in combination with an anti-HA antibody (green), anti-tubulin (magenta), anti-actin (yellow), and Hoechst for DNA. The actin furrows typical of cellularization are clearly visible using the probe but difficult to detect with actin antibodies. Scale bars: 10 μm. We next assessed the impact of a post-fixation step using 4% formaldehyde and 0.025% glutaraldehyde after incubation of pre-cellularizing S. arctica cells, where actin localizes as small cortical actin nodes38,39 with JASP-K4-488 or HAK-actin, prior to U-ExM (Figures S4B and S4C). Our results show that this crosslinking step enhances actin labeling with HAK-actin but not with JASP-K4-488, suggesting that both post-fixation step and HA-tagged actin probe are required for optimal actin detection in expanded cells. We further tested other microbial eukaryotes including two additional ichthyosporeans, Creolimax fragrantissima40 and Chromosphaera perkinsii,41 as well as the green alga Volvox tertius42 and the amoebozoan Amoeba proteus,43 (Figure S4D). Consistent with previous findings, we identified filamentous actin structures in all tested species (Figure S4D). In C. fragrantissima and C. perkinsii, actin localized at cell boundaries, whereas in V. tertius, we observed perinuclear actin rings and actin co-localizing with the flagellum.44 In A. proteus, despite the absence of tubulin labeling, likely due to a specific cell stage lacking microtubules, we detected an extensive actin network (Figure S4D).45 Additionally, we attempted to label actin in the ciliate Tetrahymena pyriformis46 and the euglenid Euglena gracilis47 but observed no specific staining (Figure S4D). This result aligns with previous reports that PHALLO-based actin labeling fails in both species,48,49,50,51,52 suggesting a lack of filamentous actin in these lineages. Together, these results suggest that HAK-actin serves as a broad-spectrum marker for visualizing filamentous actin in U-ExM-expanded samples across diverse microbial eukaryotes. Discussion In this study, we developed and validated HAK-actin, a probe optimized for actin labeling in U-ExM. By engineering the well-characterized actin ligand JASP with additional lysine residues and an HA tag, we achieved strong probe retention and robust fluorescence signal in expanded samples through post-expansion immunolabeling with conventional antibodies. This approach enables both signal amplification and greater flexibility in fluorophore selection. Our results show that HAK-actin overcomes key limitations of existing ExM-compatible actin markers, including fluorophore signal dilution and the restrictions associated with other pre-expansion labeling. Importantly, our approach is compatible with U-ExM, cryo-ExM, and iU-ExM. We show that HAK-actin reliably labels actin filaments in both chemically fixed and cryo-fixed samples. Furthermore, we demonstrate the versatility of this probe across diverse biological systems, ranging from mammalian cells and tissues to microbial eukaryotes. The overall labeling density obtained with our probe was comparable to that achieved with conventional antibodies, indicating that the probe efficiently accesses and binds its target structures. Nevertheless, some very small or fine subcellular elements remain challenging to visualize, likely reflecting intrinsic limits in probe accessibility or steric constraints at densely packed sites. Background levels also varied depending on the preparation, with notably low background in mouse retinal tissue but markedly higher signal observed in 16× samples, suggesting that labeling quality is influenced by both sample type and species. Part of this variability may stem from the secondary antibody used to detect the HA tag, which could be optimized or substituted to further reduce nonspecific signal. Importantly, diffusion of the probe does not appear to be significantly hindered, as actin staining patterns closely resembled those obtained with standard antibody-based approaches. However, because the probe is larger than small-molecule actin markers such as PHALLO or JSLP, diffusion and tissue penetration should be considered when planning experiments, particularly in thicker samples or when longer incubation times may be required. Beyond their utility for regular cell architecture imaging, HAK-actin opens possibilities for investigating actin organization in expanded samples. The HA tag allows for selective post-expansion immunostaining, providing a versatile platform for multiplexed imaging in expansion microscopy that integrates actin visualization with other cellular components. This approach is especially beneficial for microbial eukaryotes in which actin antibodies perform poorly. Additionally, the ability to pair HAK-actin with cryo-ExM allows for more accurate preservation of cytoskeletal architecture, which is particularly valuable for studying highly dynamic processes such as cell division, migration, and intracellular trafficking. Owing to its straightforward cross-linking and post-expansion labeling strategy, which is compatible with a broad range of expansion microscopy protocols, this probe holds strong potential for adaptation across diverse ExM methodologies. In conclusion, the development of HAK-actin represents a significant step forward in the application of expansion microscopy for actin imaging. Their versatility, compatibility with multiple U-ExM protocols, and broad-spectrum applicability across different biological models establish them as a valuable tool for high-resolution cytoskeletal studies. Limitations of the study HAK-actin was developed by modifying the established F-actin binders JASP and PHALLO to enable covalent anchoring within the expansion microscopy gel and post-expansion detection via an HA tag. Although these probes exhibit broad pan-actin recognition across many species, sequence or structural divergence in actin may limit binding in certain organisms, particularly evolutionarily distant taxa. Systematic testing across a wider phylogenetic range will therefore be important to define the scope of applicability. In addition, while HAK-actin performs robustly with conventional paraformaldehyde fixation and cryofixation workflows, alternative fixation methods may reduce probe accessibility or alter filament conformation. Furthermore, in some cellular contexts, endogenous actin-binding proteins could sterically hinder probe binding. Continued application of HAK-actin across diverse biological systems and preparation conditions will be essential to delineate these boundaries and guide further optimization to enhance probe versatility. Resource availability Lead contact Requests for further information and resources should be directed to and will be fulfilled by the lead contact, Paul Guichard (paul.guichard@unige.ch). Materials availability The probe is commercially available from Spirochrome (HAK-Actin; https://spirochrome.com/product/hak-actin/). Data and code availability •Data reported in this paper will be shared by the lead contact upon request. Data reported in this paper will be shared by the lead contact upon request. •This paper does not report original code. This paper does not report original code. •Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Acknowledgments We thank M. Delous, F. Lecaignard (CRNL), S. Blondel, and A. Ruiz (GenCyTi, CRNL) for the culture iPSC-derived glutamatergic neurons. We thank Umut Batman for initial experiments. We acknowledge the contribution of SFR Santé Lyon-Est (UAR3453 CNRS, US7 Inserm, UCBL) facility: CIQLE (a LyMIC member) for the acquisition of neuron images. We also thank E. Paulin for the preliminary results obtained with cryo-expansion on U2OS. This work was supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number MB22.00075 (P.G.); the Swiss National Foundation (SNSF) 310030_205087 attributed to P.G. and V.H.; and the Pro Visu, Gelbert, and TANDEM ISREC Foundations attributed to V.H. M.O. and O.D. were supported by a Swiss National Science Foundation Starting Grant (TMSGI3_218007). Author contributions L.R., P.G., and V.H. designed the HAK probes, which were synthetized by L.R. F.L., I.M., and O.M. designed and performed experiments on U2OS cells. K.S. and M.H.L. performed the experiments on platelets and neurons. O.D. and M.O. performed experiments on protists. O.M. performed experiments on retina. P.G. and V.H. supervised the study. O.M. assembled the figures. O.M., V.H., and P.G. wrote the manuscript with input from all co-authors. Declaration of interests L.R., P.G., O.D., and V.H. are inventors of a patent application (EP25184605.1) assigned to University of Geneva covering HAK probes. L.R. owns shares of Spirochrome A.G., commercializing HAK-actin probe. STAR★Methods Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesMouse anti-tubulin (clone B-5-1-2)Sigma-AldrichT5168 RRID; RRID: AB_477579Guinea Pig anti-aTubulinABCD antibodiesAA344; RRID: AB_3678982Guinea Pig anti-bTubulinABCD antibodiesAA345; RRID: AB_3106979Rabbit Pig anti-aTubulinABCD antibodiesAA344; RRID: AB_3678982Rabbit Pig anti-bTubulinABCD antibodiesAA345; RRID: AB_3106979Rabbit anti-HA (C29F4)Cell Signaling3724RRID: AB_1549585Rat anti-HA (3F10)Roche11867423001RRID: AB_390918Mouse anti-HA Monoclonal (12CA5)Invitrogen#MA1-12429; RRID: AB_1074940Guinea Pig anti-HAABCD antibodiesAF291Alexa Fluor 488 Goat anti-guinea pig IgGInvitrogenA11073; RRID: AB_2534117Alexa Fluor 594 Goat anti-rat IgGInvitrogenA11007; RRID: AB_10561522Alexa Fluor 488 goat anti-mouse IgGInvitrogenA11029; RRID: AB_2534088Cy3 goat anti-rabbit IgGJackson111-165-003; RRID AB_2338000Mouse beta-ActinProteintech#60008-1-Ig; RRID: AB_2289225Mouse beta-ActinProteintech#66009-1-IgMouse beta-ActinDSHB#JLA20; RRID: AB_2393117Goat anti-Mouse IgG (H + L) Cross-Adsorbed Secondary Antibody, Alexa Fluor™ 568InvitrogenCatalog #A-11004; RRID: AB_2534072Donkey anti-Rat IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ 488InvitrogenCatalog #A-21208; RRID: AB_2535794Goat anti-guinea pig IgG (H + L) Cross-Adsorbed Secondary Antibody, Alexa Fluor™ 488InvitrogenCatalog #A-11073; RRID: AB_2534117Donkey anti-Rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ 488InvitrogenCatalog #A-21206; RRID: AB_2535792Donkey anti-Rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ 568InvitrogenCatalog #A-10042; RRID: AB_2534017Donkey anti-Rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ Plus 647InvitrogenCatalog #A-32795; RRID: AB_2762835Biological samplesPlatelet rich plasmaFrench Blood BankN/AChemicals, peptides, and recombinant proteinsFormalinSigma-AldrichHT5012Formaldehyde (FA)Sigma-AldrichF8775-25MLParaformaldehyde 16% (PFA)EMS15710Glutaraldehyde (GA)Sigma-AldrichG5882Phallo-4K-HAThis studyThis studyJASP-4K-HAThis studyThis studyTriton X-100MERK11869Tween 20Sigma-AldrichP1379BSAEuromedex1005–7Goat SerumThermo Fisher Scientific16210–064Acrylamide (AA)Sigma-AldrichA4058-100MLN,Nʹ-methylenbisacrylamide 2% (BIS)Sigma-AldrichM1533Sodium Acrylate 97–99% (SA)Sigma-Aldrich or homemade25 or AK Scientific408220R624Ammonium Persulfate (APS)Thermo Fisher Scientific17874Tetramethylethylendiamine (Temed)Thermo Fisher Scientific17919Poly-D-Lysine (U-ExM)Sigma-AldrichP7280/P1024Poly-D-Lysine (culture cell)Sigma-AldrichP6407DMEM/F12Sigma-AldrichD8437Neurobasal MediumThermo Fisher Scientific21103049N-2 supplementThermo Fisher Scientific17502048B-27 SupplementThermo Fisher Scientific17504044K supplementBrainXellBX-2020SM1StemCell#05711GlutaMaxSigma-AldrichG8541BDNFPeproTech450–02GDNFPeproTech450–10TGF-β1PeproTech100-21CGeltrexThermo Fisher ScientificA1413202BrainFast GlutBrainXellBX-2300BrainFast D4BrainXellBX-2040Acetone, 99.8%, Extra DryAcroSeal™, Thermo Scientific Chemicals326801000mCLINGSynaptic Systems#710 006AT1Experimental models: Cell linesCortical glutamatergic neuronsBrainXCellBX-0300U2OSATCCHTB-96; RRID: CVCL_0042Experimental models: Organisms/strainsS. arcticaDudin Lab; ATCCATCC; PRA-297C. fragrantissimaDudin Lab; ATCCATCC; PRA-284C. perkinsiiDudin Lab41,53Amoeba proteushttps://einzeller.izb.unibe.ch/101Volvox tertiushttps://einzeller.izb.unibe.ch/112Tetrahymena pyriformishttps://einzeller.izb.unibe.ch/104Euglena gracilishttps://einzeller.izb.unibe.ch/111Mus musculus C57BL6JIvan Rodriguez lab, University of GenevaGE140/34121Software and algorithmsFijihttps://imagej.net/software/fiji/downloadsN/AGraphPad Prism 10https://www.graphpad.comN/AR Studiohttps://rstudio-education.github.io/hopr/starting.htmlN/AOtherethane:propane 37%:63%PanGasN/A Experimental model and study participant details Human cell line Homo sapiens bone osteosarcoma U2OS ATCC-HTB-96 were grown in Dulbecco’s modified Eagle’s medium and GlutaMAX, supplemented with 10% fetal calf serum and penicillin and streptomycin (100 μg/mL) at 37°C in a humidified 5% CO2 incubator. All cell cultures were regularly tested for mycoplasma contaminations. Preparation of human platelet rich plasma (PRP) Whole blood collected in Na-citrate vacutainers (3 × 3.3 mL/donor) was obtained from the French blood bank. The blood was centrifuged 10 min, 400 g, RT, no break to obtain the upper phase corresponding to the PRP. To increase the platelet concentration of the PRP, 2 mL of the upper phase were removed and kept to prepare plasma (centrifuge 1 min, 12100 g, RT to sediment platelets) and the remaining upper phase was collected as the final PRP. Glutamatergic neuron culture from human iPSCs Glutamatergic neurons (BrainXell) were seeded at a density of 250 cells/mm2 onto coverslips pre-coated overnight at 37°C with poly-D-lysine (0.05mg/mL). The initial culture medium (0 Days In Vitro - DIV) consisted of a basal medium comprising: DMEM/F12 (Sigma) and Neurobasal Medium (Thermo Fisher Scientific), supplemented with N-2 supplement (Thermo Fisher Scientific), K supplement (0.5X, StemCell), SM1 (1X, StemCell), GlutaMax (0.5 mM, Sigma), BDNF (10 ng/mL, PeproTech), GDNF (10 ng/mL, PeproTech), TGF-β1 (1 ng/mL, PeproTech), Geltrex (15 μg/mL, Thermo Fisher Scientific), seeding supplement for Glutamatergic neurons (BrainFast Glut 1X, BrainXell). The BrainPhys medium (Basal medium supplemented with BrainFast D4 (BrainXell)) was gradually introduced on basal medium: 50% at 4DIV, 75% at 7DIV, and 100% at 11DIV. Then the culture media are renewed every two or three days. Mouse retina All animal experiments were conducted with the authorization numbers GE140/No national: 34121, according to the guidelines and regulations issued by the Swiss Federal Veterinary Office. Microbial eukaryotes Among the microbial eukaryotes tested, Sphaeroforma arctica (Ichthyosporea), the main species investigated, was cultured as described by.54 A cryopreserved culture (stored at −80°C since 2012) was diluted and maintained in Marine Broth 2216 (MB; BD Difco 279110 or Sigma 76448, 37.4 g/L) at 17°C. Several other microbial eukaryotes were also tested. Creolimax fragrantissima (Ichthyosporea) was maintained under similar growth conditions as S. arctica. Chromosphaera perkinsii (Ichthyosporea) was cultured as previously reported.41 Amoeba proteus (Amoebozoa), Volvox tertius (Green algae), Tetrahymena pyriformis (Ciliates), and Euglena gracilis (Euglenid) were obtained from https://einzeller.izb.unibe.ch/. Upon receipt, these species were immediately chemically fixed in 4% formaldehyde (FA). Method details Chemical synthesis All chemical reagents and anhydrous solvents for synthesis were purchased from commercial suppliers (Sigma-Aldrich, Fluka, Acros) and were used without further purification or distillation. The composition of mixed solvents is given by the volume ratio (v/v). 1H nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DPX 400 (400 MHz for 1H) with chemical shifts (δ) reported in ppm relative to the solvent residual signals (2.50 ppm for DMSO-d6). Coupling constants are reported in Hz. LC-MS was performed on a Shimadzu MS2020 connected to a Nexerra UHPLC system equipped with a Waters ACQUITY UPLC BEH Phenyl 1.7μm 2.1 × 50mm column. Buffer A: 0.05% HCOOH in H2O Buffer B: 0.05% HCOOH in acetonitrile. LC gradient: 10%–90% B within 6.0 min with 0.5 mL/min flow. Unless otherwise stated, preparative HPLC was performed on a Dionex system equipped with an UltiMate 3000 diode array detector for product visualization on a Waters SymmetryPrep C18 column (7 μm, 7.8 × 300 mm). Buffer A: 0.1% v/v TFA in H2O; Buffer B: acetonitrile. Gradient was from 10% to 90% B within 30 min with 3 mL/min flow. Peptides used in this study were ordered at Biomatik (www.biomatik.com), with 80–90% purity. Alkyne-K4-HA: H-Pra-(K)4GGSGYPYDVPDYA-NH2. Alkyne-DAP4-HA: H-Pra-(DAP)4GGSGYPYDVPDYA-NH2. Alkyne-ORN4-HA: H-Pra-(ORN)4GGSGYPYDVPDYA-NH2. Alkyne-AF4-HA: H-Pra-(AF)4GGSGYPYDVPDYA-NH2. (Pra = propargylglycine, DAP = 1,2-diaminopropionic acid, ORN = Ornithine, AF = 4-aminophenylalanine). NHS-PEG4-azide Azido-PEG4-COOH (CAS 201467-81-4) (3 mg, 10.8 μmol, 1.0 eq) was dissolved in 100 μl DMSO. DIPEA (5 μl, 29.1 μmol, 2.7 eq.) and TSTU (3.9 mg, 13.0 μmol, 1.2 eq.) were successively added and the mixture was incubated at RT for 10 min. Reaction completion was monitored by LCMS. The crude reaction mixture was used without further purification and assumed to be a 0.1 M solution of NHS-PEG4-azide. Phalloidin-PEG4-azide ((R)-4-Hydroxy-4-methyl-Orn7)-Phalloidin (CAS 87876-22-0, Bachem) (1.0mg, 1.3 μmol, 1.0 eq.) was dissolved in 100 μL DMSO. DIPEA (2 μl, 11.6 μmol, 8.9 eq.) and crude NHS-PEG4-azide (0.1 M in DMSO, 16 μl, 1.6 μmol, 1.2 eq.) were added and the reaction mixture was kept at RT for 15 min. The product was purified by preparative HPLC and lyophilized. Yield: 0.9 mg. HRMS (ESI/QTOF) m/z: [M + Na]+ Calcd for C45H66N12NaO15S + 1069.4384; Found 1069.4332. Jasp-PEG4-azide Boc-Lys-Jasplakinolide derivative (7.8mg, 10 μmol, 1.0 eq.) was dissolved 1 mL TFA/DCM 1:3 and stirred for exactly 10 min at RT. 2 mL of toluene were added and the solvents were immediately removed under reduced pressure (water bath at 35°C). The residue was dried under high vacuum for 30 min and used without further purification. The residue was dissolved in 300 μl DMSO. DIPEA (20 μl, 116 μmol, 11 eq.) and crude NHS-PEG4-azide (0.1 M in DMSO, 1.2 mL, 12 μmol, 1.2 eq.) were added and the reaction mixture was kept at RT for 15 min. The product was purified by preparative HPLC and lyophilized. Yield: 6.4 mg. 1H NMR (400 MHz, DMSO) δ 10.80 (d, J = 2.4 Hz, 1H), 9.30 (s, 1H), 8.64 (d, J = 8.8 Hz, 1H), 7.68 (dd, J = 12.5, 8.2 Hz, 2H), 7.59 (t, J = 5.9 Hz, 1H), 7.29 (d, J = 8.1 Hz, 1H), 7.17–7.09 (m, 2H), 7.09–6.99 (m, 2H), 6.99–6.91 (m, 1H), 6.74–6.65 (m, 2H), 5.51 (dd, J = 11.3, 5.1 Hz, 1H), 5.18 (ddd, J = 11.5, 8.7, 3.1 Hz, 1H), 4.92 (t, J = 6.6 Hz, 1H), 4.67 (h, J = 6.4 Hz, 1H), 4.60–4.52 (m, 1H), 3.86 (s, 2H), 3.59 (dd, J = 5.6, 4.3 Hz, 2H), 3.56 (s, 4H), 3.57–3.48 (m, 2H), 3.41–3.34 (m, 2H), 3.04 (s, 3H), 2.98–2.81 (m, 3H), 2.73–2.62 (m, 1H), 2.62–2.51 (m, 1H), 2.17 (dd, J = 14.9, 11.3 Hz, 1H), 1.90–1.77 (m, 2H), 1.73 (d, J = 14.7 Hz, 1H), 1.56–1.43 (m, 1H), 1.49 (s, 3H), 1.43–1.30 (m, 1H), 1.16 (d, J = 6.3 Hz, 3H), 1.13–1.10 (m, 2H), 0.92 (d, J = 6.7 Hz, 3H), 0.86–0.80 (m, 3H). HRMS (ESI/QTOF) m/z: [M + Na]+ Calcd for C48H68N8NaO11 + 955.4900; Found 955.4919. Jasp-PEG4-AF488 Jasp-PEG4-azide (0.20 mg, 0.30 μmol, 1 eq) was dissolved in 30 μL DMSO, mixed with Alexa 488-alkyne (0.25 mg, 0.33 μmol, 1.1 eq.) dissolved in 30 μL DMSO. Separately, 4 μL of TBTA solution (0.1 M in DMSO) was mixed with 4 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 8 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 1h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 0.35 mg, 77%. MS (ESI/single quad) m/z: [M + H3]+3 Calcd for C106H154N21O29S23+ 750.0; Found 750.0. Alkyne-K4-AF488 2-chlorotrityl resin (100 mg, 0.15 mmol, 1 eq.) was swollen in DCM and DMF for 10 min each. The resin was then reacted with a mixture of 2,2′-(Ethylenedioxy)bis(ethylamine) (0.3 mL, 2 mmol, 13.3 eq.), and DMF (1.2 mL) for 30 min at RT. The resin was filtered off and washed with DMF (5 × 3 mL). Standard Fmoc-amino acid SPPS was carried out with this resin to reach the desired sequence Ac-Pra-KKKK-PEG-NH2. Briefly, 0.5 mmol Fmoc-Lys(Boc)-OH or Fmoc-propargylglycine-OH, 0.5 mmol of COMU and 0.3 mL DIPEA were dissolved in DMF (1.2 mL). after 5 min, the orange-red mixture was added to the resin and incubated for 30 min at RT. The resin was filtered off, washed with DMF (5 × 3 mL) and incubated with 20% piperidine in DMF (2.5 mL) for 5 min. The resin was filtered off and washed with DMF (5 × 3 mL). After the synthesis, final acetylation step of the N-terminus was carried out by incubating the resin with a mixture of 0.2 mL acetic anhydride, 0.2 mL DIPEA and 1.6 mL DMF for 30 min. The resin was filtered off and washed with DMF (5 × 3 mL). The peptide was cleaved from the resin by incubation with hexafluoroisopropanol (1.5 mL) for 10 min. The resin was filtered off, washed with DCM (2mL) and the filtrate evaporated. The crude Alkyne-{K(Boc)}4-amine peptide (ca 20 mg of crude obtained) was used without further purification for the next step. Crude Alkyne-{K(Boc)}4-amine peptide (10 mg, 8.3 μmol, 1eq.) was dissolved in 0.16 mL DMSO, treated with DIPEA (14 μl, 83 μmol, 10 eq.). Separately, AF488 NHS ester (6.1 mg, 8.3 mmol, 1eq.) was dissolved in DMSO (0.16 mL) and added to the peptide-DIPEA solution. The reaction mixture was incubated at r.t. for 3h, purified by preparative HPLC and the solvents were evaporated to dryness. It is to be noted that at this stage, some unlabeled peptide coeluted with the product. The residue was dissolved in TFA/DCM 1:1 (4 mL), stirred for 15 min at RT and the solvents were evaporated to dryness. The crude product was used without further purification for the next step. HRMS (ESI/QTOF) m/z: [M + H]+ Calcd for C58H85N13O18S2+2 657.7783; Found 657.7781. Jasp-PEG4-K4-AF488 Jasp-PEG4-azide (1.1 mg, 1.18 μmol, 1 eq) was dissolved in 50 μl DMSO, mixed with Alkyne-K4-AF488 (2.2 mg, 1.20 μmol, 1 eq.) dissolved in 50 μl DMSO. Separately, 8 μl of TBTA solution (0.1 M in DMSO) was mixed with 8 μl of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 16 μl of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 1h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 1.2 mg. HRMS (ESI/QTOF) m/z: [M + H2]+2 Calcd for C106H154N21O29S2+3 749.6882; Found 749.6897. Phalloidin-PEG4-K4-HA Phalloidin-PEG4-azide (0.45 mg, 0.43 μmol, 1 eq) was dissolved in 50 μL DMSO was mixed with Alkyne-K4-HA (1.2 mg, 0.47 μmol, 1.1 eq.) dissolved in 50 μL DMSO. Separately, 4 μL of TBTA solution (0.1 M in DMSO) was mixed with 4 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 8 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 1h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 0.9 mg. HRMS (ESI/QTOF) m/z: [M + H4]+4 Calcd for C136H205N35O41S+4 754.1183; Found 754.1200. Jasp-PEG4-K4-HA (HAK-actin) Jasp-PEG4-azide (0.42 mg, 0.43 μmol, 1 eq) was dissolved in 40 μL DMSO, mixed with Alkyne-K4-HA peptide (1.2 mg, 0.47 μmol, 1.1 eq.) dissolved in 50 μL DMSO. Separately, 4 μL of TBTA solution (0.1 M in DMSO) was mixed with 4 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 8 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 1h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 1.2 mg. HRMS (ESI/QTOF) m/z: [M + H4]+4 Calcd for C139H207N31O37+4 725.6312; Found 725.6278. Jasp-PEG4-DAP4-HA A 10 mM Jasp-PEG4-azide in DMSO (100 μL, 1.0 μmol, 1.0 eq) was mixed with a 10 mM Alkyne-Dap4-HA peptide solution in DMSO (100 μL, 1.0 μmol, 1.0 eq.). Separately, 5 μL of TBTA solution (0.1 M in DMSO) was mixed with 5 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 10 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 2h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 1.9 mg. HRMS (ESI/QTOF) m/z: [M + H3]+3 Calcd for C127H182N31O37+3 911.1099; Found 911.1095. Jasp-PEG4-ORN4-HA A 10 mM Jasp-PEG4-azide in DMSO (100 μl, 1.0 μmol, 1.0 eq) was mixed with a 10 mM Alkyne-Orn4-HA peptide solution in DMSO (100 μl, 1.0 μmol, 1.0 eq.). Separately, 5 μL of TBTA solution (0.1 M in DMSO) was mixed with 5 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 10 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 4h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 2.1 mg. HRMS (ESI/QTOF) m/z: [M + H3]+3 Calcd for C135H198N31O37+3 948.4849; Found 948.4876. Jasp-PEG4-4AF4-HA A 10 mM Jasp-PEG4-azide in DMSO (100 μl, 1.0 μmol, 1.0 eq) was mixed with a 10 mM Alkyne-4AF4-HA peptide solution in DMSO (100 μl, 1.0 μmol, 1.0 eq.). Separately, 5 μl of TBTA solution (0.1 M in DMSO) was mixed with 5 μL of CuSO4 solution (0.1 M in water) and the mixture was added to the alkyne/azide mixture. 10 μL of 0.5 M Sodium ascorbate in water were finally added and the reaction mixture was briefly shaken and incubated under argon for 4h at RT. The product was purified by preparative HPLC and lyophilized. Yield: 1.3 mg. HRMS (ESI/QTOF) m/z: [M + H4]+4 Calcd for C151H199N31O37+4 759.6155; Found 759.6171. Human U2OS cells Actin probes treatment U2OS cells were grown on 12 mm coverslips. After a quick wash with PBS, they were fixed with 4% paraformaldehyde (PFA) for 5 min at RT and permeabilized with PBS/Tween 0.2% for 10 min at RT. Actin probes were added (100 nM final) after the permeabilization, in PBS/Tween 0.2% for 1h at RT. For few experiments, a post-fixation step consisting in incubation coverslips in 4% PFA +0.0125% glutaraldehyde (GA) for 15 min at RT was added. After a quick wash with PBS, coverslips were processed for immunofluorescence or U-ExM. Immunofluorescence on non-expanded U2OS cells After fixation, permeabilization, actin probe treatment, cells were insubated with DAPI (1μg/mL) for 1h RT. Fluoromount was used to mount coverslips on a glass slide. Cryo-fixation of U2OS cells The cryo-fixation procedure was performed as previously described.3 Briefly, U2OS cells grown on 12 mm diameter coverslips were plunged freezed into liquid ethane cooled at −170°C using liquid nitrogen. Coverslips were then rapidly transferred into 5mL Eppendorf tubes containing liquid nitrogen pre-cooled acetone. The samples were then incubated overnight on dry ice, with an approximate angle of 45°C, under soft shaking. The samples were subsequently rehydrated by sequential incubations in a mixture of ethanol:water as follows: EtOH 100% (5min, −20°C) - EtOH 100% (5 min, −20°C) - EtOH 95% (3 min, −20°C) - EtOH 95% (3min, −20°C) – EtOH 70% (3min, 4°C) - EtOH 50% (3min, RT) - EtOH 25% (3min, RT) - H2O 100% (RT) - PBS 1x (RT). To ensure cell permeabilization after cryo-fixation, the cells were then incubated with PBS/Tween 0.2% for 10min at RT. Actin probes (100nM final) were either added in acetone in the freeze-substitution process (strategy 1, Figure 2) or after freeze-substitution and permeabilization (strategy 2, Figure 2), in PBS/Tween 0.2%, for 1h. Then, samples were processed for U-ExM. U-ExM of PFA-fixed or cryo-fixed U2OS cells PFA- or cryo-fixed U2OS cells, treated with actin probes, were then processed for the U-ExM protocol. Briefly, coverslip was first incubated 3h in 1 mL of 2% acrylamide +1.4% formaldehyde at 37°C. Then, solution was removed and 35 μL monomer solution composed of 25 μL of sodium acrylate (stock solution at 38% [w/w] diluted with nuclease-free water), 12.5 μL of AA, 2.5 μL of N,N′-methylenebisacrylamide (BIS, 2%), and 5 μL of 10× PBS together with ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) as a final concentration of 0.5% were added on a parafilm. The coverslip was then transferred on the drop of monomer solution (cells facing down) for 5 min at 4°C followed by 30 min at 37°C. Then, the gel and the coverslip was detached and immersed in a well of a 6-well plate filled with 2mL of denaturation buffer (200 mM SDS, 200 mM NaCl, 50 mM Tris Base in water (pH 9) for 15 min at RT under shaking to allow the detachment of the gel from the coverslip. The gel was next incubated in 1.5 mL tube filled with denaturation buffer for 1 h 30 at 95°C. Finally, gel was expanded in three successive ddH2O baths of around 30 min. Round punches of 1 cm diameter were then performed and gels were either frozen in glycerol 50% (in water) or stained after 3 successive baths of PBS. Primary and secondary antibodies were incubated for 2h30 at 37°C in 1.5mL tube in a heat block with shaking in PBS BSA 2%. After each incubation, 3 successive washes with PBS Tween 0,1% of 5 min were done. Stained gels were finally expanded with 3 successive ddH2O baths of 5 min and imaged. iU-ExM of cryo-fixed U2OS cells Cryo-fixed U2OS cells were processed for iterative expansion microscopy (iU-ExM) protocol, adapted from established procedures. In brief, cells were fixed in a mixture of 1.4% formaldehyde (FA) and 2% acrylamide (AAm) in 1× PBS for 3 h at 37°C. Gelation was carried out by transferring the coverslip into humidified chamber on ice, where monomer solution containing 10% AAm, 19% sodium acrylate (SA), 0.1% N,N′-dihydroxyethylene bisacrylamide (DHEBA), and 0.25% APS/TEMED was added. After 15 min of incubation on ice, polymerization was completed at 37°C for 45 min. Once gelled, the samples were immersed in denaturation buffer (200 mM SDS, 200 mM NaCl, 50 mM Tris base, pH 6.8) in a 6-well plate until the gel detached from the coverslip. Gels were then transferred to 1.5 mL tubes with fresh denaturation buffer and incubated at 85°C for 1.5 h. This was followed by three 30-min washes in deionized water to initiate expansion. The partially expanded gels were subsequently immunostained and embedded in a second gel for further expansion. For re-embedding, 13 mm punches of the gel were placed in 6-well plates containing 2 mL of a neutral monomer mix (10% AAm, 0.05% DHEBA, 0.05% APS/TEMED) and incubated on ice with gentle agitation for 25 min. Samples were mounted on microscope slides, excess monomer was blotted away using Kimwipes, and a 22 × 22 mm coverslip was applied. Remaining space was filled with monomer solution, and polymerization was carried out in a humidified chamber at 37°C for 1 h. Following embedding, the gels were treated with an anchoring solution (1.4% FA and 2% AAm) at 37°C for 3 h under shaking, washed with PBS, and then incubated in a second expansion monomer solution (10% AAm, 19% SA, 0.1% BIS, 0.05% APS/TEMED) for 25 min on ice with agitation. Excess solution was removed, the gels were covered with coverslips, and polymerization was completed at 37°C for 1 h in a humidified environment. To finalize the protocol, the gels were treated with 200 mM NaOH for 1 h at room temperature with shaking, followed by multiple washes in PBS (∼20 min each) until neutral pH was achieved. Full expansion was accomplished through successive incubations in deionized water until the gel size stabilized. Imaging Image acquisition was performed on an inverted confocal Leica Stellaris 8 microscope or on a Leica Thunder DMi8 microscope using a 20× (0.40 NA) or 63× (1.4 NA) oil objective with Lightning or Thunder SVCC (small volume computational clearing) mode at max resolution, adaptive as “Strategy” and water as “Mounting medium” to generate deconvolved images. 3D stacks were acquired with 0.12 μm z-intervals and an x, y pixel size of 35 nm. Platelet samples Platelet Spreading Platelet rich plasma (PRP) was diluted in PBS to a concentration of 2.5x106 platelets/ml (plasma concentrations were kept constant at 0.3%) and 400 μL of this suspension was transferred into each well of a 24 well plate containing plasma cleaned coverslips. The plate is centrifuged for 3 min, 600 g at RT to allow synchronized contact of all platelets with the glass surface. The plate is then placed in a cell culture incubator at 37°C. After 60 min platelets are fixed with isotonic formalin (9 volumes formalin/1 volume 10xPBS) for 15 min at RT and proceed for immunofluorescence and expansion. Platelet immunolabeling Fixed platelets were permeabilized with PBS-TritonX100 0.2% for 15 min, washed and incubated in blocking buffer (3% BSA and 10% goat serum in PBS) for 1h at RT. Coverslips were incubated for 60 min with either Jasp-PEG4-HA (1/200) or Phallo-PEG4-HA (1/200) in PBS Tween 0.1%. For non-expanded conditions, samples were washed in PBS and incubated ON at 4°C with mouse-anti tubulin (clone B-5-1-2, 1/500) and rabbit-anti HA (1/500) in blocking buffer. Coverslips were then incubated with secondary antibodies (1/500) for 1h at RT in the dark and mounted on glass slides using Mowiol. For expanded conditions, samples were washed and incubated 1h30 at RT with mouse-anti tubulin (clone B-5-1-2, 1/250), washed in PBS and PBS/0.2% Triton X-100 and incubated with secondary antibody (1/250). Samples were then expanded (see below) and incubated with rabbit-anti HA (1/340) in blocking buffer for 3h 30 min at RT. After 3 washes in PBS PBS/0.2% Triton X-100, they were incubated with secondary antibody (1/500) in blocking buffer for 90 min at RT in the dark. Gels were then washed in PBS and PBS/0.2% Triton X-100 and expanded 3 times in ddH20. Platelet expansion After three washing steps, samples were processed for U-ExM essentially as described by.2,55 Briefly, stained platelets were incubated in PBS/0.7% formaldehyde/1% acrylamide overnight at RT. The coverslips were then placed upside down onto an ice-cold 35 μL drop of gelation solution (PBS/19% sodium acrylate/10% acrylamide/0.1% bisacrylamide) pipetted onto parafilm on ice immediately after addition of TEMED and APS both to a final concentration of 0.5%. After 5 min of incubation on ice, the samples were transferred to 37°C for 1 h. The coverslips plus gel facing up were then incubated in denaturation buffer (5.7% SDS/0.2M NaCI/50mM Tris, pH9) for 15 min at RT with gentle agitation to detach the gel from the coverslip. The gels were then transferred into an eppendorf tube with fresh denaturation buffer and boiled for 30 min at 95°C. Gels were washed in ddH20 twice and incubated in PBS for immunostaining. Platelets data acquisition Images were acquired using either a wide-field Olympus epifluorescence microscope (BX41) equipped with a Plan 100×/1.25NA oil objective, a DP70 camera and the acquisition software analySIS (non-expanded) or a confocal microscope (Nikon A1R + MP) equipped with a home-made adaptive optics corrector was used with a 40× long distance water immersion objective (U-ExM). Glutamatergic neuron Fixation and actin probe labeling 4DIV and 21DIV glutamatergic neurons were fixed in a mixture of paraformaldehyde and glutaraldehyde (3%–0.1%) in PBS for 20 min at room temperature, washed and incubated in Neurons were incubated in Jasp-PEG4-HA (400 nM) diluted in PBS-Tween20 for 1h at RT. Expansion and immunostaining Samples were washed and proceeded for expansion as described in.55 Briefly, Fixed coverslips were incubated in a mixture of acrylamide 2%, Formaldehyde 1.4% diluted in PBS for 3h at 37°C. Gelation was performed on ice by placing the coverslips upside down on a 35mL drop of monomer solution (19% sodium acrylate, 10% acrylamide, 0.1% BIS-acrylamide, 0.5% TEMED and APS). After 5 min incubation on ice, coverslips were placed at 37°C for 30 min in a humid chamber. Gels were next incubated in denaturation buffer for 10 min at RT and transferred in Eppendorf tube at 95°C for 90 min. Gels were washed twice in ddH2O and placed in PBS to perform immunostaining. Gels were incubated in PBS-BSA2% in presence of anti-HA, anti-aTubulin and anti-bTubulin (1/250 each) for 4h at RT with agitation. After three washes in PBS-Tween0.1%, gels were incubated in PBS-BSA2% with secondary antibodies anti-rat A594 and anti-GuineaPig A488 for 3h at RT with agitation. Gels were washed in PBS-Tween0.1% and expanded in ddH2O. Data acquisition Images of glutamatergic neurons were acquired using an IX 83 inverted microscope (Olympus), equipped with a Yokagawa CSU-X1 Spinning Disk Unit (Borealis technology) for homogeneous illumination and Ixon3 888 EM-CCD camera (Andor). The oil immersion Plan Apochromat 60x/1.42 NA objective from Olympus was used for all acquisitions. Retina tissue Retina tissue dissection Mouse eyes were harvested by postmortem enucleation on adult mice committed to sacrifice. After having performed a small incision in the anterior part, eyes were directly fixed in 4% PFA for 15 min at RT. Then, eyes were immersed in PBS Tween 0.2% for 30 min. Actin probes (200 nM final) were then added in PBS Tween 0,2% for 1h15 at RT. After a quick wash, retinas were then dissected as previously described.31 Using microscissors, cornea and lens were discarded, and retinas were detached from the sclera. Retinas were then incised on 4 different points to flatten it as a clover inside a 10-mm microwell of a 35-mm Petri dish (P35G-1.5-10-C, MatTek) to allow their processing by Ultrastructure expansion microscopy (U-ExM). Retina expansion Briefly, Retinas were first incubated overnight (ON) in 100 μL of 2% acrylamide +1.4% formaldehyde at 37°C. The day after, solution was removed and 35 μL monomer solution (MS) composed of 25 μL of sodium acrylate (stock solution at 38% [w/w] diluted with nuclease-free water), 12.5 μL of AA, 2.5 μL of N,N′-methylenebisacrylamide (BIS, 2%), and 5 μL of 10× PBS was added for 90 min at RT. Then, MS was removed and 90 μL of MS was added together with ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) as a final concentration of 0.5% for 45 min at 4°C first followed by 3 h incubation at 37°C. A 24-mm coverslip was added on top to close the chamber. Next, the coverslip was gently removed and 1 mL of denaturation buffer (200 mM SDS, 200 mM NaCl, 50 mM Tris Base in water (pH 9)) was added into the MatTek dish for 15 min at RT with shaking. Then, careful detachment of the gel from the dish with a spatula was performed, and the gel was incubated in 1.5 mL eppendorf tube filled with denaturation buffer for 1 h at 95°C and then ON at RT. The day after, the gel was cut as a square around the retina that is still visible and expanded in three successive ddH2O baths. Then, the gel was manually sliced with a razorblade to obtain ∼0.5 mm thick transverse sections of the retina that were then processed for immunostaining. For this, primary antibodies were incubated overnight at 4°C, then washed 3 times with PBS Tween 0,1%, and secondary antibodies were incubated 3h at 37°C and also washed 3 times with PBS Tween 0,1%. Finally, gel slices were expanded with 3 baths of 5 min in ddH2O for imaging. Microbial eukaryotes Immunofluorescence on non-expanded S. arctica cells The cell culture flasks were scraped, and the suspension was transferred to 15 mL Falcon tubes to sediment for 15–30 min. The supernatant was removed, and the cells were transferred to 1.5 mL microfuge tubes, followed by the addition of fixative for 30 min. The cells were fixed with 4% formaldehyde in 250 mM sorbitol solution, washed twice with 1× phosphate-buffered saline (PBS), and resuspended in 20–30 μL of PBS. Permeabilization was performed using six freeze-thaw cycles (liquid N2, 10 s; 42°C, 1 min), followed by blocking in 2% bovine serum albumin (BSA) in PBST (1× PBS with 0.1% Tween 20). For actin staining using the actin probes in this study, the probes were diluted 1:500 from a 100 μM stock solution and incubated for 1 h before additional crosslinking with 4% formaldehyde and 0.025% glutaraldehyde for 10 min. For antibody labeling, primary antibodies were used at 1:300 and incubated overnight at 37°C. The antibodies included anti-tubulin rabbit IgG (AA344 and AA345, ABCD Antibodies), anti-actin mouse antibody JLA20 (DSHB), HA-tag mouse monoclonal antibody (12CA5, Invitrogen, MA1-12429), and anti-HA guinea pig IgG (AF291, ABCD Antibodies). This was followed by three washes for 10 min at room temperature and the addition of secondary antibodies. The following secondary antibodies were used at 1:500: Goat anti-mouse IgG (H + L) cross-adsorbed secondary antibody, Alexa Fluor 568 (Invitrogen, A-11004); goat anti-guinea pig IgG (H + L) cross-adsorbed secondary antibody, Alexa Fluor 488 (Invitrogen, A11073); donkey anti-rabbit IgG (H + L) highly cross-adsorbed secondary antibody, Alexa Fluor 488 (Invitrogen, A-21206); donkey anti-rabbit IgG (H + L) highly cross-adsorbed secondary antibody, Alexa Fluor 568 (Invitrogen, A10042); and donkey anti-rabbit IgG (H + L) highly cross-adsorbed secondary antibody, Alexa Fluor Plus 647 (Invitrogen, A32795). Incubation was performed for 2–5 h at 37°C. The cells were then washed and resuspended in fresh 1× PBS for imaging. DNA was stained with Hoechst 33352 at a final concentration of 0.4 μM. U-ExM of microbial eukaryotes U-ExM was adapted from Gambarotto et al. and performed as previously described (Shah et al., Nature, 2024; Mikus et al., 2025). Briefly, following fixation, actin-probe incubation, and crosslinking as described previously, the fixed cells were allowed to sediment onto 6 mm poly-L-lysine-coated coverslips for 1 h. This was followed by anchoring in an acrylamide/formaldehyde solution (1% acrylamide, 0.7% formaldehyde) overnight at 37°C. A monomer solution (19% (wt/wt) sodium acrylate (Chem Cruz, AKSci 7446-81-3), 10% (wt/wt) acrylamide (Sigma-Aldrich, A4058), 0.1% (wt/wt) N,N′-methylenebisacrylamide (Sigma-Aldrich, M1533) in PBS) was used for gelation, and gels were allowed to polymerize for 1 h at 37°C in a moist chamber. For denaturation, gels were transferred to denaturation buffer (50 mM Tris, pH 9.0, 200 mM NaCl, 200 mM SDS) for 15 min at room temperature and then incubated at 95°C for 1.5 h. Following denaturation, expansion was performed with several water exchanges. After expansion, gel diameter was measured to determine the expansion factor. For all U-ExM images, scale bars indicate actual size, rescaled according to the gel expansion factor. Immunostaining was performed as described above. All antibodies were prepared in 3% PBS with 0.1% Tween 20. Primary antibodies were incubated overnight at 37°C, and secondary antibodies were incubated for 2–5 h at 37°C. Data acquisition Widefield imaging of S. arctica was carried out using a fully motorized Nikon Ti2-E inverted epifluorescence microscope, equipped with a PFS4 hardware autofocus system, a Lumencor SOLA SMII light source, and a Hamamatsu ORCA-spark Digital CMOS camera. Imaging was performed with CFI Plan Fluor objectives: 20× (0.50 NA), 40× (Air), and 60× Oil (0.5–1.25 NA). Confocal microscopy of microbial eukaryotes was conducted using a Leica SP8 upright confocal microscope with an HC PL APO 40×/1.25 glycerol objective. Expansion factor Expansion factor (EF) has been calculated by measuring the gel after expansion and dividing the measure by the size of the sample pre-expansion (Range between 4 and 4.3 throughout experiments). All scale bars shown in the paper are corrected to the EF. Quantification and statistical analysis Quantification Signal intensity measurement in U2OS Signal intensity was measured on non-denoised (raw) images with FiJi.56 For this, a square ROI was drawn by hand in the background (outside of cells) where the mean gray value was measured for both actin probe (488 channel), and Beta-actin (568 channel). Then, the same ROI was used in 3 different locations inside the cell to measure the mean gray value for both actin probe (488 channel), and Beta-actin (568 channel). Finally, the average mean gray value of actin probe signal per cell was divided by the background of actin probe signal on the same image. 5 cells were measured per condition, and 3 independent experiments were performed. To compare actin probe signal with beta-actin signal, the final ratio (signal/background) of actin probe was divided by the ratio (signal/background) of beta-actin. Staining efficiency in S. arctica Antibody and probe-staining efficiency in S. arctica was measured by counting the number of cells with visible actin (488 channel) or tubulin (568 channel) structures. In S. arctica actin network can be organized as nodes, filaments or bundles depending on the cell stage, whereas microtubules are present throughout the life cycle. For each condition, between 30 and 246 cells were measured per replicate, and at least three independent experiments, with two technical replicates each, were performed. For anti-actin antibody labeling, only 2 replicates with 2 technical replicates were performed. Signal intensity measurement in S. arctica Signal intensity in S. arctica was measured from maximum projection images using Fiji. A circular region of interest (ROI) was manually drawn around individual cells, and the mean gray value was quantified for the actin probe (488 channel). A total of 35 cells were measured per condition across two independent experiments. Statistical analysis in S. arctica All comparisons in Figures 3B and S5C were performed between two groups based on the figure layout, using a nonparametric Mann-Whitney test. Error bars on the graphs represent standard deviation SD (±), and significance levels are indicated as follows: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. All statistical analyses were conducted using R and RStudio. Statistics for U2OS measurements Comparisons of two groups were realized using the nonparametric Mann-Whitney test. Comparisons of more than two groups were made using the nonparametric Kruskal–Wallis test followed by post hoc test (Dunn’s for multiple comparisons) to identify all the significant group differences. Every measurement was performed on 3 different experiments, with 5 images on each experiment and 3 measurements on each image. Data are all represented as a scatter dot plot with centerline as mean. The graphs with error bars indicate SD (±) and the significance level is denoted as usual (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). All the statistical analyses were performed using Prism10. Published: April 16, 2026 Footnotes Supplemental information can be found online at https://doi.org/10.1016/j.crmeth.2026.101408. Contributor Information Virginie Hamel, Email: virginie.hamel@unige.ch. Paul Guichard, Email: paul.guichard@unige.ch. Supplemental information Document S1. Figures S1–S4 Document S2. Article plus supplemental information References Associated Data Supplementary Materials Document S1. Figures S1–S4 Document S2. Article plus supplemental information Data Availability Statement •Data reported in this paper will be shared by the lead contact upon request. Data reported in this paper will be shared by the lead contact upon request. •This paper does not report original code. This paper does not report original code. •Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.